£425.00

The 2016-2021 Outlook for Anti-Migraine Drugs in Latin America

Econometrics

Price data last checked 18 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£425 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 73 days · 73 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 73 days • 1 price levels

Days at Price

Price Analysis

Most common price: £425 (73 days, 100.0%)

Price range: £425 - £425

Price levels: 1 different prices over 73 days

Description

This econometric study covers the outlook for anti-migraine drugs in Latin America. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-a-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the countries in Latin America). This study gives, however, my estimates for the latent demand, or the P.I.E. for anti-migraine drugs in Latin America. It also shows how the P.I.E. is divided across the national markets of Latin America. For each country, I also show my estimates of how the P.I.E. grows over time (positive or negative growth). In order to make these estimates, a multi-stage methodology was employed that is often taught in courses on international strategic planning at graduate schools of business.

Product Specifications

Format: paperback
ASIN: B0161T5WVK
Category: Books > Subjects > Business, Finance & Law > Economics > Econometrics
Domain: Amazon UK
Release Date: 21 May 2015
Listed Since: 01 October 2015

The 2016-2021 Outlook for Anti-Migraine Drugs in Latin America

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

The 2016-2021 Outlook for Anti-Migraine Drugs in Asia

The 2016-2021 Outlook for Anti-Migraine Drugs in Europe

The 2016-2021 Outlook for Anti-Migraine Drugs in North America & the Caribbean

The 2016-2021 Outlook for Anti-Migraine Drugs in Oceana

The 2011-2016 Outlook for Anti-Migraine Drugs in The Middle East

The 2021-2026 World Outlook for Anti-Migraine Drugs

The 2016-2021 Outlook for Anti-Migraine Drugs in the United States

The 2023-2028 Outlook for Anti-Migraine Drugs in the United States

The 2016-2021 Outlook for Anti-Migraine Drugs in Greater China

The 2023-2028 Outlook for Anti-Migraine Drugs in India

The 2025-2030 World Outlook for Anti-Migraine Drugs

The 2023-2028 World Outlook for Acute-Treatment Migraine Drugs

The 2023-2028 Outlook for Anti-Migraine Drugs for US Zip Codes

Traitements de crise et traitements de fond de la migraine: Aspects pharmacothérapeutiques (Omn.Univ.Europ.)

Springer - Migraine and Headache Disorders Global Perspective

Management of Migraine Pain: Emerging Opportunities and Challenges

Academic Press - Interventional Management of Migraines

Migraine, Words and Fiction

Migraine

The Biochemistry of Migraine

Comorbid Conditions in the Treatment of Headache

Clinical Scales for Headache Disorders

Neuroimaging of Headache Disorders

Interventional Management of Headache Pain